Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth

Cancer Cell. 2004 Dec;6(6):597-609. doi: 10.1016/j.ccr.2004.10.012.

Abstract

p53-dependent apoptosis is a major determinant of its tumor suppressor activity and can be triggered by hypoxia. No p53 target is known to be induced by p53 or to mediate p53-dependent apoptosis during hypoxia. We report that p53 can directly upregulate expression of Bnip3L, a cell death inducer. During hypoxia, Bnip3L is highly induced in wild-type p53-expressing cells, in part due to increased recruitment of p53 and CBP to Bnip3L. Apoptosis is reduced in hypoxia-exposed cells with functional p53 following Bnip3L knockdown. In vivo, Bnip3L knockdown promotes tumorigenicity of wild-type versus mutant p53-expressing tumors. Thus, Bnip3L, capable of attenuating tumorigenicity, mediates p53-dependent apoptosis under hypoxia, which provides a novel understanding of p53 in tumor suppression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Blotting, Western
  • CREB-Binding Protein
  • Caspase 3
  • Caspases / metabolism
  • Cell Hypoxia
  • Cell Line, Tumor
  • Cell Proliferation
  • Chromatin Immunoprecipitation
  • Cisplatin / pharmacology
  • Doxycycline / pharmacology
  • Fluorouracil / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes, Reporter / genetics
  • Glucose Transporter Type 1
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Membrane Proteins / physiology*
  • Mice
  • Mice, Nude
  • Monosaccharide Transport Proteins / metabolism
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Nuclear Proteins / metabolism
  • Oligonucleotide Array Sequence Analysis
  • Protein Binding / drug effects
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins / physiology*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Repressor Proteins / genetics
  • Trans-Activators / metabolism
  • Transfection
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Tumor Suppressor Protein p53 / physiology*
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism
  • Tumor Suppressor Proteins / physiology*
  • Xenograft Model Antitumor Assays

Substances

  • BNIP3 protein, human
  • BNIP3L protein, human
  • Glucose Transporter Type 1
  • Membrane Proteins
  • Monosaccharide Transport Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Repressor Proteins
  • SLC2A1 protein, human
  • Trans-Activators
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • tetracycline resistance-encoding transposon repressor protein
  • CREB-Binding Protein
  • CREBBP protein, human
  • Crebbp protein, mouse
  • CASP3 protein, human
  • Casp3 protein, mouse
  • Caspase 3
  • Caspases
  • Doxycycline
  • Cisplatin
  • Fluorouracil